This Kalorama Information report, Companion Diagnostics Markets (A Realistic Assessment of the Opportunities, Challenges, Key Players and Important Trends in Personalized Medicine) is truly a real-world guide to the potential market for companion diagnostics. Essentially the co-development of testing products to enhance the value and efficacy of a therapeutic, companion diagnostics is widely seen as an important growth strategy in both the diagnostic and pharmaceutical industries. It is envisioned as a pathway to personalized medicine, where the right therapeutic is selected for the right patient. Personalized medicine is one of the key trends in healthcare, and it's no surprise that there is great enthusiasm in many quarters of the in vitro industry, pharmaceutical companies and the investment community about companion diagnostics. But will the concept work in the fashion that the industry is envisioning? Who will succeed and with what strategy? How much can companies expect to earn in this field? What strategies should companies adopt to thrive in this market? In this report, Kalorama Information analyst Kenneth Krul, PhD. brings a real-world view to the concept of companion diagnostics and the likely scenario given market conditions. He addresses the myriad challenges that diagnostic and pharmaceutical companies will face in this endeavor. He outlines strategies that will be more successful. His analysis includes:
The following companies and their efforts in companion diagnostics are profiled in this report:
Related Reports: What is Working in IVD: Successful Commercialization of New Products and TechnologiesJul 1, 2009 - KLI2283426 - $2,500.00 Drug Delivery Markets: Oral Delivery Jul 1, 2009 - KLI2290102 - $2,995.00 Advances in Ophthalmology: Markets in the Treatment of Eye Disorders and Corrective Vision, 2nd Ediiton Jun 1, 2009 - KLI2271479 - $3,500.00 Vaccines 2009: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry Jun 1, 2009 - KLI2155319 - $3,995.00 Rx to OTC Switches 2009 May 1, 2009 - KLI2196300 - $3,500.00 H1N1 (Swine Influenza) Market Assessment (Latest Data, Company Profiles, Implications for Immunoassays and Molecular Assays) May 1, 2009 - KLI2241990 - $800.00 The World Market for Cancer Therapeutics and Biotherapeutics, 3rd. Edition May 1, 2009 - KLI2218043 - $3,995.00 Cell Culture: The World Market for Media, Sera and Reagents, 2nd Edition May 1, 2009 - KLI2091313 - $3,995.00 World Veterinary Health Products (Animal Pharmaceuticals, Vaccines, OTC and Performance Enhancers) May 1, 2009 - KLI1829596 - $3,500.00 Who is Who in Clinical Diagnostics in China (Manufacturers and Distributors Profiles, Market, Industry Overview ) May 1, 2009 - KLID2217449 - $3,995.00 |
800.298.5603
Int'l: +1.240.747.3096
Questions?
Contact a research specialist >
Most Popular Research
The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 6th Edition [with 2009 economy preface]
The Clinical Laboratory Services Market (Growth Opportunities, Competitive Analysis and Competitor Profiles)
The Worldwide Market for Cancer Diagnostics, 3rd Edition
The World Market for Molecular Diagnostics
Cell-Based Diagnostics: Technology, Applications, and Markets, 2nd Edition
Companion Diagnostics Markets (A Realistic Assessment of the Opportunities, Challenges, Key Players and Important Trends in 'Theranostics' and Personalized Medicine)
|
|||||||||
|
Privacy Policy
|
Terms and Conditions
|
Site Map
|
Return Policy
|
Press
|
Help FAQs
|